(Q39281860)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Gerolama Condorelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

C Quintavalle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

E Donnarumma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

M Iaboni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

G Roscigno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

M Garofalo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

G Romano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

P De Marinis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

C M Croce

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

10 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

4001-4008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2012.410

12 February 2020

exact match

0 references

cites work

Survival comparison between glioblastoma multiforme and other incurable cancers

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Advances in the genetics of glioblastoma: are we reaching critical mass?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

TRAIL: a multifunctional cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

TRAIL signalling: decisions between life and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

The potential of TRAIL for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

New insights into apoptosis signaling by Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MicroRNAs in diseases and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

miR221/222 in cancer: their role in tumor progression and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MicroRNAs as regulators of death receptors signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Identification and functional characterization of microRNAs involved in the malignant progression of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Targeting miR-21 in glioma: a small RNA with big potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.410

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json

release_7o3m767cjzbrnpl4ry7upk7mki

12 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7o3m767cjzbrnpl4ry7upk7mki

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964638%20AND%20SRC:MED&resulttype=core&format=json